Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Non-interventional, Multicenter Study Aimed at Collecting Retrospective/Prospective 648/96 Italian Registry Data Related to Lenalidomide (Revlimid®) Prescription to Patients With Myelodysplastic Syndromes

NCT01347944 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT01347944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01347944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Non-interventional, Multicenter Study Aimed at Collecting Retrospective/Prospective 648/96 Italian Registry Data Related to Lenalidomide (Revlimid®) Prescription to Patients With Myelodysplastic Syndromes
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
June 30, 2013
Enrollment
149 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome